Elevated Placental Growth Factor Levels Are Associated With Adverse Outcomes at Four-Year Follow-Up in Patients With Acute Coronary Syndromes
- 17 January 2006
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 47 (2), 307-311
- https://doi.org/10.1016/j.jacc.2005.08.063
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Prognostic Value of Placental Growth Factor in Patients With Acute Chest PainJAMA, 2004
- Soluble CD40 Ligand in Acute Coronary SyndromesThe New England Journal of Medicine, 2003
- Placental Growth Factor (PlGF) and Its Receptor Flt‐1 (VEGFR‐1)Annals of the New York Academy of Sciences, 2002
- Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1Nature Medicine, 2002
- Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery DiseaseJAMA, 2001
- Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofibanThe Lancet, 1999
- Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T LevelsThe New England Journal of Medicine, 1999
- Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE studyThe Lancet, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenThe New England Journal of Medicine, 1997
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaThe New England Journal of Medicine, 1994